Results 21 to 30 of about 1,044,325 (153)
Highlights Annual numbers of hospitalizations of patients with peripheral artery disease (PAD) in coprevalence with diabetes mellitus (DM) increased significantly during the observational period from 2005 to 2019. Age and comorbidity‐burden of PAD patients with DM aggravated over time, whereas major adverse cardiac and cerebrovascular events and in ...
Volker H. Schmitt +6 more
wiley +1 more source
Highlights Many studies have reported that the triglyceride glucose (TyG) index is an inexpensive biochemical marker to assess metabolic and cardiovascular diseases. Our findings indicate that the TyG index is nonlinearly associated with the risk of new‐onset elevated carotid intima‐media thickness (CIMT) during a follow‐up of 4.3 years.
Xiaojing Jia +19 more
wiley +1 more source
Highlights In this ESCAPE‐extension study, cilostazol treatment reduced the incidence of adverse cardiovascular events in patients with type 2 diabetes when compared with aspirin for a 5.2‐year median follow‐up. During the follow‐up period, no adverse events were noted in the cilostazol group that exceeded those in the aspirin group.
Minji Sohn, Eun Ju Chun, Soo Lim
wiley +1 more source
目的探讨副干酪乳杆菌(Lpa)抑制动脉粥样硬化进展的作用及其机制。方法采用8周龄的雄性载脂蛋白E基因敲除(ApoE-/-)小鼠建立动脉粥样硬化模型,随机分为3组: ①正常饲料对照组,10只ApoE-/-小鼠; ②模型组:10只ApoE-/-小鼠,高脂高胆固醇饲料+PBS灌胃;③副干酪乳杆菌干预组:10只ApoE-/-小鼠,高脂高胆固醇饲料+副干酪乳杆菌灌胃。油红O染色观察小鼠主动脉大体及主动脉窦的病理形态学变化;免疫荧光染色观察巨噬细胞脂质蓄积及胆固醇吞噬情况;Western ...
杨嘉璐 +6 more
core +1 more source
Effect of type 2 diabetes on A disintegrin and metalloprotease 10 2型糖尿病对解整合素金属蛋白酶10表达的影响
Highlights a disintegrin and metalloprotease 10 (ADAM10), a sheddase responsible for the cleavage of a variety of cell surface molecules, has been implicated in the pathogenesis of Alzheimer disease, atherosclerosis, and inflammatory and neoplastic disorders, and systemic ADAM10 concentration may potentially be used as a prognostic biomarker. Our study
Sum Lam +3 more
wiley +1 more source
Highlights A nested, nationwide, propensity‐matched cohort study was carried out using the Clinical Practice Research Datalink with 1186 patients with no past history of ASCVD, half of whom had undergone bariatric surgery. Bariatric surgery was associated with improved ASCVD outcomes and lower mortality, highlighting a potential prognostic role of the ...
Maddalena Ardissino +6 more
wiley +1 more source
动脉粥样硬化是一种较为严重的心脑血管疾病,对人体健康有着十分严重的危害。在临床上,通心络胶囊是一种常用的药物,能够有效的保护心脏、血管、血液,对于脑梗死、心肌梗死、冠心病、动脉粥样硬化等疾病的治疗中,均可发挥出良好的效果。在实际治疗中,药物可通过稳定斑块、调节血脂、改善心功能、缓解急性冠状动脉综合征等作用 ...
方鉴
core +1 more source
溶血磷脂酸在动脉粥样硬化病变中的作用 The Effects of Lysophosphatidic Acid in Atherosclerotic Lesion
动脉粥样硬化是一种严重的慢性动脉炎症性疾病,可以引起冠状动脉粥样硬化性心脏病 和缺血性卒中等疾病。溶血磷脂酸在动脉粥样硬化的发生发展过程中起着至关重要的作用,它通过 对血管内皮细胞、血管平滑肌细胞、单核-巨噬细胞、成纤维细胞、树突状细胞、T淋巴细胞及血小板 等发挥作用促进动脉粥样硬化和血栓形成。探讨溶血磷脂酸在动脉粥样硬化发展中的作用和相关 病理生理机制有助于探索抗动脉粥样硬化的潜在药物和干预措施。 Abstract: Atherosclerosis is a severe and ...
张建平,李亚峰,郭庚
doaj +1 more source
动脉粥样硬化性疾病的DNA甲基化改变 DNA Methylation Changes in Atherosclerotic Diseases
动脉粥样硬化是缺血性卒中、冠心病等心脑血管疾病的主要病因。既往研究发现DNA甲基化在动脉粥样硬化斑块的发生、进展中具有重要调节作用,并在病变的不同阶段表现出细胞特异性改变。本文综述了动脉粥样硬化斑块中内皮细胞、平滑肌细胞、巨噬细胞以及动脉粥样硬化性疾病患者外周血免疫细胞中DNA甲基化模式改变相关研究,总结了动脉粥样硬化性卒中患者的DNA甲基化改变,以期为新靶点的发现和疾病诊治提供新的思路。 Abstract: Atherosclerosis is a major cause of ...
伊珞,周宏宇,仇鑫,李子孝,王拥军
doaj +1 more source
目的 基于头颈联合HR-MRI技术,探讨在60岁及以下无传统心脑血管高危因素的人群中,颈动脉几何形态与大脑中动脉(middle cerebral artery,MCA)粥样硬化的相关性,寻找MCA粥样硬化的潜在预测指标。 方法 回顾性分析来自60岁及以下无传统心脑血管高危因素患者的150个同侧前循环动脉单位,根据MCA是否存在动脉粥样硬化斑块将其分为MCA粥样硬化(+)组和MCA粥样硬化(-)组。分析两组间颈动脉分叉夹角、颈动脉管腔面积比值和颈内动脉颅外段及颅内段的形态分型 ...
刘伊桐,黄燕琪,李明利,冯逢,高山,徐蔚海
doaj +1 more source

